Oceania · Markets & Finance · Stockhead

Long Shortz Optiscan: FDA submission opens path to US commercialisation

Published by Stockhead · Australia 3 h ago

US FDA 510(k) submission for InForm digital pathology device is a major milestone towards potential US commercialisation. ... Read More The post Long Shortz Optiscan: FDA…

Read the full article on Stockhead Sign in to save

MediaNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (stockhead.com.au)

Also worth reading

Business News (WA)

Long Shortz Optiscan: FDA submission opens path to US commercialisation

Share

Also worth reading

Almost $60b wiped from ASX in bond-linked bloodbath

The death of the free quote: Why tradies are charging customers upfront

The Reverse Centaur

Doctors and allied health professionals walk off job en masse amid pay disputes

AMP, CFS and Vision Super get the Epic Retirement Tick

Melbourne Uni concrete recycling spinout cements $750,000 pre-Seed